Seer Inc Cl A (SEER)

$1.72 -0.03 (-1.71%)
Market Cap 99.87M
Revenue (ttm) 16.58M
Net Income (ttm) -73.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -443.91%
Debt to Equity Ratio 0.00
Volume 230,179
Avg Vol 380,198
Day's Range N/A - N/A
Shares Out 56.42M
Stochastic %K 6%
Beta 1.63
Analysts Strong Sell
Price Target $4.00

Company Profile

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any l...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 453 0000
Website: seer.bio
Address:
3800 Bridge Parkway, Suite 102, Redwood City, United States
Kaxle
Kaxle May. 14 at 12:23 PM
$SEER 📰 **`$SEER`**: Billion-Dollar AI deal, $100M in Acquisitions, $25M Founder Buy-In – Diginex Details Expansion Push
0 · Reply
MarketBeat
MarketBeat May. 14 at 4:13 AM
https://marketbeat.com/a/8653211/ $SEER Seer Q1 Earnings Call Highlights
0 · Reply
EarningsInsider
EarningsInsider May. 13 at 9:33 PM
https://www.marketbeat.com/earnings/reports/2026-5-13-seer-inc-stock/ $SEER Seer Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 13 at 8:25 PM
$SEER Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.30 up 11.76% YoY • Reported revenue of $2.79M down -33.58% YoY • Seer continues to expect full year 2026 revenue to be in the range of $16M to $18M, representing growth of 3% at the midpoint over full year 2025.
0 · Reply
DARKP00L
DARKP00L May. 13 at 12:00 PM
$SEER 07:04 on May. 13 2026 Seer Files Patent Infringement Suit Against Nanomics Biotechnology #tradeideas
0 · Reply
Shane_Drinion
Shane_Drinion May. 12 at 2:36 PM
$SEER Increase the bid, Radoff. Make it interesting.
0 · Reply
focafoca99
focafoca99 May. 4 at 8:39 PM
$SEER designated Anthony Bazarko as its new Chief Commercial Officer.
0 · Reply
focafoca99
focafoca99 Apr. 29 at 2:23 PM
$SEER is facing pressure from the Radoff-JEC group after Seer rejected its April 24 acquisition proposal.
0 · Reply
DARKP00L
DARKP00L Apr. 27 at 11:54 AM
$SEER 07:22 on Apr. 27 2026 Seer Announces That Its Board Reviewed And Unanimously Rejected The Revised Unsolicited, Non-Binding Proposal From Radoff-JEC Group #tradeideas
0 · Reply
notreload_ai
notreload_ai Apr. 24 at 5:00 PM
Investors offered to buy $SEER for $2.35/share plus extra future payout; stock rose after takeover bid. Board responds by May 2. https://notreload.xyz/xy/radoff-jec-group-boosts-seer-takeover-bid/
0 · Reply
Latest News on SEER
Radoff, Torok submit proposal to acquire Seer for $2.40 per share in cash

2026-05-14T16:59:13.000Z - 1 day ago

Radoff, Torok submit proposal to acquire Seer for $2.40 per share in cash

The Radoff-JEC Group Submits its Third Non-Binding Proposal to Acquire Seer, Inc.

May 14, 2026, 8:00 AM EDT - 1 day ago

The Radoff-JEC Group Submits its Third Non-Binding Proposal to Acquire Seer, Inc.

Seer, Inc. Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 2 days ago

Seer, Inc. Earnings Call Transcript: Q1 2026

Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook

May 13, 2026, 4:05 PM EDT - 2 days ago

Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook

Seer files patent infringement lawsuit against Nanomics Biotechnology

2026-05-13T12:22:54.000Z - 2 days ago

Seer files patent infringement lawsuit against Nanomics Biotechnology

Seer Files Patent Infringement Lawsuit Against Nanomics

May 13, 2026, 7:00 AM EDT - 2 days ago

Seer Files Patent Infringement Lawsuit Against Nanomics

Seer appoints Anthony Bazarko as chief commercial officer

2026-05-04T11:26:35.000Z - 11 days ago

Seer appoints Anthony Bazarko as chief commercial officer

Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer

May 4, 2026, 7:00 AM EDT - 11 days ago

Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer

Seer initiated with a Buy at Canaccord

2026-05-04T09:22:56.000Z - 11 days ago

Seer initiated with a Buy at Canaccord

Seer to Report First Quarter 2026 Financial Results on May 13, 2026

Apr 29, 2026, 4:05 PM EDT - 16 days ago

Seer to Report First Quarter 2026 Financial Results on May 13, 2026

Radoff-Torok respond to Seer’s rejection of acquisition proposal

2026-04-29T15:14:03.000Z - 16 days ago

Radoff-Torok respond to Seer’s rejection of acquisition proposal

The Radoff-JEC Group Responds to Seer, Inc.'s Rejection of April 24th Acquisition Proposal

Apr 29, 2026, 8:00 AM EDT - 16 days ago

The Radoff-JEC Group Responds to Seer, Inc.'s Rejection of April 24th Acquisition Proposal

Seer board rejects revised proposal from Bradley Radoff, Michael Torok

2026-04-27T11:55:25.000Z - 18 days ago

Seer board rejects revised proposal from Bradley Radoff, Michael Torok

Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group

Apr 27, 2026, 7:00 AM EDT - 18 days ago

Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group

Radoff-JEC submit improved proposal to acquire Seer for $2.35 per share in cash

2026-04-24T11:13:29.000Z - 21 days ago

Radoff-JEC submit improved proposal to acquire Seer for $2.35 per share in cash

The Radoff-JEC Group Submits Improved Non-Binding Proposal to Acquire Seer, Inc.

Apr 24, 2026, 7:00 AM EDT - 21 days ago

The Radoff-JEC Group Submits Improved Non-Binding Proposal to Acquire Seer, Inc.

Seer says will review $2.25 per share takeover proposal

2026-04-13T18:00:11.000Z - 4 weeks ago

Seer says will review $2.25 per share takeover proposal

Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group

Apr 13, 2026, 1:55 PM EDT - 4 weeks ago

Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group

Radoff-JEC Group submits proposal to acquire Seer for $2.25 per share plus CVR

2026-04-13T12:18:57.000Z - 4 weeks ago

Radoff-JEC Group submits proposal to acquire Seer for $2.25 per share plus CVR

The Radoff-JEC Group Submits Non-Binding Proposal to Acquire Seer, Inc.

Apr 13, 2026, 8:00 AM EDT - 4 weeks ago

The Radoff-JEC Group Submits Non-Binding Proposal to Acquire Seer, Inc.

Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples

Apr 9, 2026, 8:00 AM EDT - 5 weeks ago

Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples

PTAB upholds Seer patent for nano- and microparticles in challenge by Bruker

2026-03-30T11:22:52.000Z - 6 weeks ago

PTAB upholds Seer patent for nano- and microparticles in challenge by Bruker

BRKR

Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries

Mar 30, 2026, 7:00 AM EDT - 6 weeks ago

Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries

Seer, Inc. Transcript: TD Cowen 46th Annual Health Care Conference

Mar 4, 2026, 11:10 AM EST - 2 months ago

Seer, Inc. Transcript: TD Cowen 46th Annual Health Care Conference

Seer shareholder group sends letter to Seer independent directors

2026-03-04T13:19:33.000Z - 2 months ago

Seer shareholder group sends letter to Seer independent directors

The Radoff-JEC Group Sends Open Letter to Seer, Inc. Unconflicted Independent Directors Meeta Gulyani and Nicolas Roelofs

Mar 4, 2026, 8:00 AM EST - 2 months ago

The Radoff-JEC Group Sends Open Letter to Seer, Inc. Unconflicted Independent Directors Meeta Gulyani and Nicolas Roelofs

Seer, Inc. Earnings Call Transcript: Q4 2025

Feb 26, 2026, 4:30 PM EST - 2 months ago

Seer, Inc. Earnings Call Transcript: Q4 2025

Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets

Feb 26, 2026, 4:06 PM EST - 2 months ago

Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets

Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook

Feb 26, 2026, 4:05 PM EST - 2 months ago

Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook

The Radoff-JEC Group issues open letter to Seer

2026-02-23T14:26:15.000Z - 2 months ago

The Radoff-JEC Group issues open letter to Seer

The Radoff-JEC Group Issues Open Letter to Seer Inc.'s Board of Directors Regarding the Immediate Need for Significant Change

Feb 23, 2026, 8:30 AM EST - 2 months ago

The Radoff-JEC Group Issues Open Letter to Seer Inc.'s Board of Directors Regarding the Immediate Need for Significant Change

Seer announces participation at 2026 U.S. HUPO

2026-02-19T12:37:16.000Z - 3 months ago

Seer announces participation at 2026 U.S. HUPO

Leading Scientists Demonstrate How Seer's Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026

Feb 19, 2026, 7:00 AM EST - 3 months ago

Leading Scientists Demonstrate How Seer's Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026

Seer to Participate in the TD Cowen 46th Annual Health Care Conference

Feb 18, 2026, 4:05 PM EST - 3 months ago

Seer to Participate in the TD Cowen 46th Annual Health Care Conference

Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Feb 5, 2026, 4:05 PM EST - 3 months ago

Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Seer announces publication of GWAS using Proteograph Product Suite

2025-12-01T12:05:13.000Z - 5 months ago

Seer announces publication of GWAS using Proteograph Product Suite

Nature Genetics Study Validates Seer's Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers

Dec 1, 2025, 7:00 AM EST - 5 months ago

Nature Genetics Study Validates Seer's Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers

Seer, Inc. Transcript: CG MedTech, Diagnostics and Digital Health & Services Forum

Nov 20, 2025, 4:00 PM EST - 6 months ago

Seer, Inc. Transcript: CG MedTech, Diagnostics and Digital Health & Services Forum

Seer announces new data at HUPO World Congress 2025

2025-11-07T12:17:25.000Z - 6 months ago

Seer announces new data at HUPO World Congress 2025

Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025

Nov 7, 2025, 7:00 AM EST - 6 months ago

Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025

Seer, Inc. Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 6 months ago

Seer, Inc. Earnings Call Transcript: Q3 2025

Seer Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 4:05 PM EST - 6 months ago

Seer Reports Third Quarter 2025 Financial Results

Seer to Participate in Upcoming November Investor Conferences

Oct 29, 2025, 4:05 PM EDT - 7 months ago

Seer to Participate in Upcoming November Investor Conferences

Seer to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 16, 2025, 4:05 PM EDT - 7 months ago

Seer to Report Third Quarter 2025 Financial Results on November 6, 2025

Seer to highlight how proteomics complements genomics at ASHG 2025

2025-10-10T11:05:21.000Z - 7 months ago

Seer to highlight how proteomics complements genomics at ASHG 2025

Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025

Oct 10, 2025, 7:00 AM EDT - 7 months ago

Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025

Seer, Inc. Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 9, 2025, 12:20 PM EDT - 8 months ago

Seer, Inc. Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Seer appoints Isaac Ro to board of directors

2025-09-02T11:11:00.000Z - 9 months ago

Seer appoints Isaac Ro to board of directors

Seer Appoints Isaac Ro to its Board of Directors

Sep 2, 2025, 7:00 AM EDT - 9 months ago

Seer Appoints Isaac Ro to its Board of Directors

WGS

Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 26, 2025, 4:05 PM EDT - 9 months ago

Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Seer, Inc. Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 13, 2025, 9:00 AM EDT - 9 months ago

Seer, Inc. Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Seer, Inc. Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 10 months ago

Seer, Inc. Earnings Call Transcript: Q2 2025

Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook

Aug 6, 2025, 4:05 PM EDT - 10 months ago

Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook

Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference

Jul 31, 2025, 4:05 PM EDT - 10 months ago

Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference

Seer to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 22, 2025, 4:05 PM EDT - 10 months ago

Seer to Report Second Quarter 2025 Financial Results on August 6, 2025

Seer announces the launch of a population-level study on biomakers

2025-06-01T20:40:09.000Z - 1 year ago

Seer announces the launch of a population-level study on biomakers

Seer's Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults

Jun 1, 2025, 7:00 AM EDT - 1 year ago

Seer's Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults

Seer announces launch of its new Proteograph Product Suite

2025-05-29T11:16:17.000Z - 1 year ago

Seer announces launch of its new Proteograph Product Suite

Seer Redefining Deep Unbiased Proteomics with Launch of New Proteograph Workflow at ASMS 2025, Enabling Previously Unattainable Scale and Efficiency

May 29, 2025, 7:00 AM EDT - 1 year ago

Seer Redefining Deep Unbiased Proteomics with Launch of New Proteograph Workflow at ASMS 2025, Enabling Previously Unattainable Scale and Efficiency

Seer backs FY25 revenue view $17M-$18M, consensus $17.52M

2025-05-13T20:46:36.000Z - 1 year ago

Seer backs FY25 revenue view $17M-$18M, consensus $17.52M

Seer, Inc. Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Seer, Inc. Earnings Call Transcript: Q1 2025

Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook

May 13, 2025, 4:05 PM EDT - 1 year ago

Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook

Seer to Report First Quarter 2025 Financial Results on May 13, 2025

Apr 24, 2025, 4:05 PM EDT - 1 year ago

Seer to Report First Quarter 2025 Financial Results on May 13, 2025

Seer, Inc. Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 4, 2025, 11:50 AM EST - 1 year ago

Seer, Inc. Transcript: TD Cowen 45th Annual Healthcare Conference

Seer, Inc. Earnings Call Transcript: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Seer, Inc. Earnings Call Transcript: Q4 2024

Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook

Feb 27, 2025, 4:05 PM EST - 1 year ago

Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook

Seer to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 21, 2025, 7:00 AM EST - 1 year ago

Seer to Participate in the TD Cowen 45th Annual Health Care Conference

Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025

Feb 20, 2025, 7:00 AM EST - 1 year ago

Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025

Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Feb 13, 2025, 4:15 PM EST - 1 year ago

Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Seer, Inc. Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 6:00 PM EST - 1 year ago

Seer, Inc. Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference

Jan 2, 2025, 4:05 PM EST - 1 year ago

Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference

Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Nov 21, 2024, 4:05 PM EST - 1 year ago

Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Seer, Inc. Transcript: Guggenheim Securities Inaugural Healthcare Innovation Conference

Nov 11, 2024, 11:30 AM EST - 1 year ago

Seer, Inc. Transcript: Guggenheim Securities Inaugural Healthcare Innovation Conference

Seer, Inc. Earnings Call Transcript: Q3 2024

Nov 6, 2024, 4:30 PM EST - 1 year ago

Seer, Inc. Earnings Call Transcript: Q3 2024

Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific

Nov 6, 2024, 4:03 PM EST - 1 year ago

Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific

Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer's, Lung Cancer, and More at ASHG 2024

Oct 31, 2024, 7:00 AM EDT - 1 year ago

Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer's, Lung Cancer, and More at ASHG 2024

Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer's, Population Health, and Xenotransplantation at HUPO 2024

Oct 21, 2024, 7:00 AM EDT - 1 year ago

Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer's, Population Health, and Xenotransplantation at HUPO 2024

Seer, Inc. Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Sep 5, 2024, 4:05 PM EDT - 1 year ago

Seer, Inc. Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 22, 2024, 4:05 PM EDT - 1 year ago

Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Seer Appoints Nicolas Roelofs to its Board of Directors

Aug 14, 2024, 4:05 PM EDT - 1 year ago

Seer Appoints Nicolas Roelofs to its Board of Directors

Seer, Inc. Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Aug 14, 2024, 3:00 PM EDT - 1 year ago

Seer, Inc. Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference

Aug 9, 2024, 7:00 AM EDT - 1 year ago

Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference

Seer, Inc. Earnings Call Transcript: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 1 year ago

Seer, Inc. Earnings Call Transcript: Q2 2024

Seer to Report Second Quarter 2024 Financial Results on August 8, 2024

Jul 18, 2024, 4:03 PM EDT - 1 year ago

Seer to Report Second Quarter 2024 Financial Results on August 8, 2024

Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery

Jun 11, 2024, 11:11 AM EDT - 2 years ago

Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery

Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ's Early Cancer Detection Study

Jun 2, 2024, 10:55 AM EDT - 2 years ago

Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ's Early Cancer Detection Study

Seer, Inc. Earnings Call Transcript: Q1 2024

May 8, 2024, 4:30 PM EDT - 2 years ago

Seer, Inc. Earnings Call Transcript: Q1 2024

Seer Reports First Quarter 2024 Financial Results

May 8, 2024, 4:05 PM EDT - 2 years ago

Seer Reports First Quarter 2024 Financial Results

Kaxle
Kaxle May. 14 at 12:23 PM
$SEER 📰 **`$SEER`**: Billion-Dollar AI deal, $100M in Acquisitions, $25M Founder Buy-In – Diginex Details Expansion Push
0 · Reply
MarketBeat
MarketBeat May. 14 at 4:13 AM
https://marketbeat.com/a/8653211/ $SEER Seer Q1 Earnings Call Highlights
0 · Reply
EarningsInsider
EarningsInsider May. 13 at 9:33 PM
https://www.marketbeat.com/earnings/reports/2026-5-13-seer-inc-stock/ $SEER Seer Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 13 at 8:25 PM
$SEER Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.30 up 11.76% YoY • Reported revenue of $2.79M down -33.58% YoY • Seer continues to expect full year 2026 revenue to be in the range of $16M to $18M, representing growth of 3% at the midpoint over full year 2025.
0 · Reply
DARKP00L
DARKP00L May. 13 at 12:00 PM
$SEER 07:04 on May. 13 2026 Seer Files Patent Infringement Suit Against Nanomics Biotechnology #tradeideas
0 · Reply
Shane_Drinion
Shane_Drinion May. 12 at 2:36 PM
$SEER Increase the bid, Radoff. Make it interesting.
0 · Reply
focafoca99
focafoca99 May. 4 at 8:39 PM
$SEER designated Anthony Bazarko as its new Chief Commercial Officer.
0 · Reply
focafoca99
focafoca99 Apr. 29 at 2:23 PM
$SEER is facing pressure from the Radoff-JEC group after Seer rejected its April 24 acquisition proposal.
0 · Reply
DARKP00L
DARKP00L Apr. 27 at 11:54 AM
$SEER 07:22 on Apr. 27 2026 Seer Announces That Its Board Reviewed And Unanimously Rejected The Revised Unsolicited, Non-Binding Proposal From Radoff-JEC Group #tradeideas
0 · Reply
notreload_ai
notreload_ai Apr. 24 at 5:00 PM
Investors offered to buy $SEER for $2.35/share plus extra future payout; stock rose after takeover bid. Board responds by May 2. https://notreload.xyz/xy/radoff-jec-group-boosts-seer-takeover-bid/
0 · Reply
focafoca99
focafoca99 Apr. 24 at 2:03 PM
$SEER proposes an improved non-binding buyout offer from the Radoff-JEC Group at $2.35 per share plus a CVR.
0 · Reply
OpenOutcrier
OpenOutcrier Apr. 24 at 12:12 PM
$SEER (+4.6% pre) Radoff-JEC Group raises acquisition offer for SEER to $2.35 per share - SI https://ooc.bz/l/99880
0 · Reply
DARKP00L
DARKP00L Apr. 24 at 11:05 AM
$SEER 07:03 on Apr. 24 2026 Seer Announces Nonbinding Takeover Proposal From Shareholder Radoff-JEC Group At $2.35 Per Share In Cash Plus One Contingent Value Right #tradeideas
0 · Reply
OpenOutcrier
OpenOutcrier Apr. 13 at 8:00 PM
RECAP 4/13 Chatter: $LULU - TX AG Probe $TBRG + IKS Healthcare $DELL $QPG + $NVDA $SEER + Raoff-JEC Live Breaking trading news www.openoutcrier.com
0 · Reply
notreload_ai
notreload_ai Apr. 13 at 5:05 PM
Activist investors offer to buy $SEER for $2.25/share cash + CVR, criticize CEO, and push board to respond by Apr 22. https://notreload.xyz/activist-investors-bid-for-seer/
0 · Reply
focafoca99
focafoca99 Apr. 13 at 3:42 PM
$SEER received a non-binding buyout proposal from the Radoff-JEC Group, which says it is prepared to move quickly and without financing conditions.
0 · Reply
DARKP00L
DARKP00L Apr. 13 at 12:14 PM
$SEER 08:10 on Apr. 13 2026 The Radoff-JEC Group Submits Non-Binding Proposal To Acquire Seer For $2.25/Share #tradeideas
0 · Reply
focafoca99
focafoca99 Apr. 9 at 8:12 PM
$SEER will help profile 10,000 samples in the PRECISE SG100K project using Proteograph.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 2 at 11:06 PM
$SEER RSI: 32.26, MACD: -0.0474 Vol: 0.05, MA20: 1.74, MA50: 1.83 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
IvansDrivin
IvansDrivin Mar. 25 at 2:08 PM
$SEER that's some activist letter. CEO gettin' dropped? Stock has done literally nothing for a decade.
0 · Reply
dkempire
dkempire Mar. 4 at 5:59 PM
$SEER looking good
0 · Reply